- ENG - English
- HIN - हिन्दी
- GUJ - ગુજરાતી
- MAR - मराठी
- BEN - বাংলা
- KAN - ಕನ್ನಡ
- ORI - ଓଡିଆ
- TEL - తెలుగు
- TAM - தமிழ்
- NSE13:34 | 22-11-2019
- BSE13:41 | 22-11-2019
Cipla Ltd Stock Price F & O Quotes
Cipla Ltd. Quarterly Results
Cipla Ltd Share Price
Cipla Ltd Risk Return Comparisonwith peersNew
Cipla Ltd Financial Comparisonwith peers
Cipla Ltd Share Holding as on 30-09-2019
|Category||No. of shares||Percentage|
MF Ownership Of Cipla Ltd. Shares
Liquid, Ultra Short Term funds and FMPs are not taken into account.More Schemes
About Cipla Ltd.
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 39136.48 Crore) operating in Pharmaceuticals sector.
Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11968.44 Crore to Sales Value (96.72 % of Total Sales), Other Operating Revenue which contributed Rs 167.72 Crore to Sales Value (1.35 % of Total Sales), Export Incentives which contributed Rs 155.27 Crore to Sales Value (1.25 % of Total Sales), Royalty Income which contributed Rs 50.68 Crore to Sales Value (0.40 % of Total Sales) and Scrap which contributed Rs 31.90 Crore to Sales Value (0.25 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 4264.24 Crore, up 9.50 % from last quarter Sales of Rs 3894.46 Crore and up 8.01 % from last year same quarter Sales of Rs 3947.93 Crore Company has reported net profit after tax of Rs 480.44 Crore in latest quarter.
The company’s top management includes Dr.Peter Mugyenyi, Dr.Y K Hamied, Mr.Adil Zainulbhai, Mr.Ashok Sinha, Mr.M K Hamied, Mr.Peter Lankau, Mr.S Radhakrishnan, Mr.Umang Vohra, Ms.Naina Lal Kidwai, Ms.Punita Lal, Ms.Samina Vaziralli. Company has Walker Chandiok & Co. LLP as its auditoRs As on 30-09-2019, the company has a total of 806,077,497 shares outstanding.